LFMD logo

LFMD
LifeMD Inc

3,589
Mkt Cap
$205.06M
Volume
387,816.00
52W High
$15.84
52W Low
$2.56
PE Ratio
-10.19
LFMD Fundamentals
Price
$4.50
Prev Close
$4.24
Open
$4.25
50D MA
$4.20
Beta
1.72
Avg. Volume
1.2M
EPS (Annual)
-$0.2263
P/B
13.40
Rev/Employee
$498,856.55
$123.43
Loading...
Loading...
News
all
press releases
Is CAH Becoming the Backbone of US Healthcare Infrastructure?
Cardinal Health is expanding beyond drug distribution into specialty care, logistics and nuclear medicine, deepening its role in US healthcare infrastructure.
News Placeholder
More News
News Placeholder
Bloomberg Businessweek Daily 5/18/2026
Today, Matt Schettenhelm, Bloomberg Intelligence Senior Litigation Analyst, breaks down a California's jury's rejection of Elon Musk's claim that Sam Altman betrayed OpenAI's original mission when it...
News Placeholder
LifeMD (NASDAQ:LFMD) Posts Quarterly Earnings Results, Misses Estimates By $0.06 EPS
LifeMD (NASDAQ:LFMD - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.20) EPS for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.06). LifeMD had a negative return on equity of 83.93% and a net margin of 6.58%.The business had...
News Placeholder
LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates
LifeMD (LFMD) delivered earnings and revenue surprises of -42.86% and +3.97%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
LifeMD, Inc. (NASDAQ:LFMD) Receives Average Recommendation of "Moderate Buy" from Analysts
LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) has been given an average rating of 'Moderate Buy' by the nine brokerages that are covering the firm, MarketBeat reports. One analyst has rated the stock...
News Placeholder
Hims & Hers Expands DTC Platform to Broaden Access to Personal Care
HIMS broadens its DTC platform with GLP-1 access, a new Benefits hub and global expansion to broaden convenient, personalized care.
News Placeholder
LifeMD's (LFMD) Buy Rating Reiterated at BTIG Research
BTIG Research restated a "buy" rating and issued a $10.00 price objective on shares of LifeMD in a report on Monday...
News Placeholder
LifeMD (LFMD) Projected to Post Quarterly Earnings on Tuesday
LifeMD (NASDAQ:LFMD) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at...
News Placeholder
Meta, Microsoft to Trim Workforces Amid AI Spending Bloomberg Businessweek Daily 4/23/2026
On today's episode of Bloomberg Businessweek Daily, Carol Massar and Tim Stenovec speak with Bloomberg Tech Co-Host Ed Ludlow about Meta and Microsoft looking to trim their workforces amid heavy AI...
News Placeholder
LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?
LifeMD (LFMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available